【摘要】 2019年12月底,中国暴发了一场不明微生物引发的病毒性肺炎。经研究确认,该不明微生物为一种新的冠状病毒,即严重急性呼吸综合征冠状病毒2(severe acute respiratory syndrome coronavirus 2, SARS-CoV-2),2020年2月,WHO将SARS-CoV-2感染的肺炎正式命名为新型冠状病毒肺炎(coronavirus disease-2019, COVID-19)。随着对SARS-CoV-2及其引发肺炎研究的深入,SARS-CoV-2特点、COVID-19临床及流行病学特征、临床诊治技术等研究内容陆续在国内外杂志报道。本文对已开展的COVID-19研究工作梳理总结,围绕溯源分析、检测手段、临床表现、药物研发、病毒传播等5个方面进行综述,以期对临床及科研工作者提供帮助。更多还原

【Abstract】 At the end of December 2019, viral pneumonia caused by unknown microorganisms is reported in Wuhan, China. Studies confirmed that a novel coronavirus was identified, namely severe acute respiratory syndrome coronavirus 2(SARS-CoV-2). In February 2020, WHO officially named SARS-CoV-2-infected pneumonia as coronavirus disease 2019(COVID-19). With the research progress on SARS-CoV-2 and its incurred pneumonia, SARS-CoV-2 characteristics, COVID-19 clinical and epidemiological features, clinical diagnosis and treatment technology have been reported in domestic and foreign journals. In this article, the existing COVID-19 researches, and review 5 aspects such as traceability analysis, detection methods, clinical manifestations, drug development and viral transmission were summarized, with expectations to provide assistance for clinicians and scientific researchers.更多还原